SONN insider transaction filings
Sonnet BioTherapeutics Holdings, Inc. — 19 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-12-04. Screen SONN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-04 | 4 | Kenney Richard T — Chief Medical Officer | Disposition to issuer (D): 9,374 · Option exercise (M): 86,505 · Tax withholding (F): 16,891 · Disposition to issuer (D): 69,614 · Option exercise (M): 163,760 · Disposition to issuer (D): 163,760 · +3 more | EDGAR |
| 2025-12-03 | 4 | MCANDREW STEPHEN J — Chief Business Officer | Disposition to issuer (D): 6,446 | EDGAR |
| 2025-12-03 | 4 | Dexter Susan — Director | Disposition to issuer (D): 9,643 | EDGAR |
| 2025-12-03 | 4 | Rao Raghu — Chief Executive Officer, Director | Disposition to issuer (D): 22,356 | EDGAR |
| 2025-12-03 | 4 | Bhatt Nailesh — Director | Disposition to issuer (D): 10,547 | EDGAR |
| 2025-12-03 | 4 | McNeill Lori — Director | Disposition to issuer (D): 4,394 | EDGAR |
| 2025-12-03 | 4 | Cini John K. — Director | Disposition to issuer (D): 14,116 | EDGAR |
| 2025-12-03 | 4 | Griffith Donald J. — Chief Financial Officer, Director | Disposition to issuer (D): 10,375 | EDGAR |
| 2025-12-03 | 4 | Dyrness Albert D. — Director | Disposition to issuer (D): 4,537 | EDGAR |
| 2025-08-21 | 4 | Kenney Richard T — Chief Medical Officer | Grant/award (A): 86,505 (derivative) · Grant/award (A): 320,000 (derivative) · Grant/award (A): 200 (derivative) | EDGAR |
| 2025-07-15 | 4 | Dyrness Albert D. — Director | Grant/award (A): 4,000 | EDGAR |
| 2025-07-15 | 4 | Rao Raghu — Interim CEO, Director | Grant/award (A): 20,000 | EDGAR |
| 2025-07-15 | 4 | McNeill Lori — Director | Grant/award (A): 4,000 | EDGAR |
| 2025-07-15 | 4 | MCANDREW STEPHEN J — Chief Business Officer | Grant/award (A): 6,000 | EDGAR |
| 2025-07-15 | 4 | Kenney Richard T — Chief Medical Officer | Grant/award (A): 8,000 | EDGAR |
| 2025-07-15 | 4 | Griffith Donald J. — Chief Financial Officer, Director | Grant/award (A): 10,000 | EDGAR |
| 2025-07-15 | 4 | Dexter Susan — Chief Technical Officer | Grant/award (A): 8,000 | EDGAR |
| 2025-07-15 | 4 | Cini John K. — Chief Scientific Officer | Grant/award (A): 12,000 | EDGAR |
| 2025-07-15 | 4 | Bhatt Nailesh — Director | Grant/award (A): 10,000 | EDGAR |
Recent 8-K events — Sonnet BioTherapeutics Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-12-03 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-29 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-08-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-07-18 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-07-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-02 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SONN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →